Senti Biosciences, Inc. (SNTI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.3687 |
| Open | 0.3800 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.3600 - 0.3888 |
| 52-week range | 0.2700 - 1.1000 |
| Volume | |
| Avg. volume | 118,431 |
| Market cap | 16.929M |
| Beta (5Y monthly) | 2.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
The FDA clears Senti Bio's (SNTI) investigational new drug application for SENTI-202 for the treatment of relapsed/refractory hematologic malignancies, including acute myeloid leukemia. Stock rises.
- Zacks
Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates
Senti Biosciences, Inc. (SNTI) delivered earnings and revenue surprises of 12.50% and 27.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Here's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
© 2024 Yahoo. All rights reserved.